Last 5 years124 documents Updated 24 Aug

Abbott - AI

Overview · What matters about Abbott right now?

Research

What is being built

Documents by area

  • 42
  • 34
  • 19
  • 17
  • 5

What's new · What is newest about Abbott?

Newest in innovation

Diagnostic performance of the Myocardial-Ischaemic-Injury index machine-learning algorithm in patients with an initial indeterminate troponin Paper · Wake Forest University Artificial Intelligence in IPMN diagnosis: bridging promise and clinical reality Paper · Jinnah Sindh Medical University The Impact of Artificial Intelligence on the Labor Market Paper · COMSATS University Islamabad Machine learning approach for automated localization of ventricular tachycardia ablation targets from substrate maps: development and validation in a porcine model Paper · University College London Exploratory Algorithms to Aid in Risk of Malignancy Prediction for Indeterminate Pulmonary Nodules Paper · Abbott

Newest in the market

Abbott (NYSE:ABT) Valuation Focus Grows With Lingo AI Expansion - Kalkine Media News · Kalkine Media Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health? - Yahoo Finance News · Yahoo Finance Google AI health coach to use Abbott glucose data - AI News News · AI News Google and Abbott Partner to Boost Metabolic Health Insights - Healthcare Digital News · Healthcare Digital Abbott's Lingo to link with Google Health app to get AI recommendations - 디지털투데이 News · 디지털투데이

Track this radar to get each update by email.

Research · What is Abbott building?

Where the work is growing

Dot size: documents that year
Where the work is growing
Area2021 2022 2023 2024 2025 2026 so farTotal
0
40
34
0
19
0
17
0
0
0
0
0
5

What problems are they working on?

Size and shade: documents

Largest 15 of 17 problems

Latest in innovation

Diagnostic performance of the Myocardial-Ischaemic-Injury index machine-learning algorithm in patients with an initial indeterminate troponin Paper · Wake Forest University Artificial Intelligence in IPMN diagnosis: bridging promise and clinical reality Paper · Jinnah Sindh Medical University The Impact of Artificial Intelligence on the Labor Market Paper · COMSATS University Islamabad Machine learning approach for automated localization of ventricular tachycardia ablation targets from substrate maps: development and validation in a porcine model Paper · University College London Exploratory Algorithms to Aid in Risk of Malignancy Prediction for Indeterminate Pulmonary Nodules Paper · Abbott

Market · What is Abbott bringing to market?

Latest in the market

Abbott (NYSE:ABT) Valuation Focus Grows With Lingo AI Expansion - Kalkine Media News · Kalkine Media Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health? - Yahoo Finance News · Yahoo Finance Google AI health coach to use Abbott glucose data - AI News News · AI News Google and Abbott Partner to Boost Metabolic Health Insights - Healthcare Digital News · Healthcare Digital Abbott's Lingo to link with Google Health app to get AI recommendations - 디지털투데이 News · 디지털투데이

Rules and standards in the news

Abbott (ABT) Wins FDA and EU Approval for an AI-Powered Tool That Guides Artery Stent Placement - Yahoo Finance News · Yahoo Finance Abbott gets FDA nod, CE mark for AI-enabled imaging device - MedTech Dive News · MedTech Dive How Investors Are Reacting To Abbott (ABT) Gaining FDA, CE Clearance For AI-Guided Ultreon 3.0 - Yahoo Finance News · Yahoo Finance Abbott’s latest-generation Ultreon software gains FDA approval, CE mark - Cardiovascular News News · cardiovascularnews.com Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform - Yahoo Finance News · Yahoo Finance

Strategy · Where is Abbott putting its money and effort?

How far along each area is

Innovation Market A year ago
How far along each area is
Selling
Selling
Selling
Selling

Money, launches and partners

Launches and deployments

Abbott Debuts GenAI ‘Libre Assist’ to Tackle Mealtime Decision Fatigue News · hitconsultant.net · Abbott launches AI-based Libre Assist, its new in-app feature for meal planning - Fierce Biotech News · Fierce Biotech · Abbott Debuts GenAI ‘Libre Assist’ to Tackle Mealtime Decision Fatigue - HIT Consultant News · HIT Consultant · Why Abbott’s Ultreon 3.0 could reshape stent planning in complex coronary disease - PharmaDeviceNews News · pharmadevicenews.com · Abbott, Google Health team up on AI-powered health insights app - Fierce Biotech News · Fierce Biotech ·

Partnerships

Diagnostic performance of the Myocardial-Ischaemic-Injury index machine-learning algorithm in patients with an initial indeterminate troponin Paper · Wake Forest University, Abbott, University of Maryland ·

Legal actions

Abbott IP chief: ‘Firms without AI policies scare me’ - Life Sciences IP Review News · Life Sciences IP Review ·

New to this radar

Diagnostic performance of the Myocardial-Ischaemic-Injury index machine-learning algorithm in patients with an initial indeterminate troponin Paper · University of Maryland, Wake Forest University ·

Where it bets · Where does Abbott place its bets?

Data · The evidence behind this radar

What do you want to know next?

Ask about anything in this radar's 124 documents.

Get the report

For your team, or for an AI tool.

Share it

Send your team the link to this radar.